Exelixis Inc (NAS:EXEL)
$ 35.81 -0.04 (-0.11%) Market Cap: 10.23 Bil Enterprise Value: 9.24 Bil PE Ratio: 22.96 PB Ratio: 4.50 GF Score: 91/100

Exelixis Inc at Jefferies Healthcare Conference Transcript

Jun 08, 2022 / 05:30PM GMT
Release Date Price: $19.22 (-1.28%)
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

So good afternoon, everyone. I hope you're all doing well. I have the -- for those who don't know me, my name is Akash Tewari. I'm a biotech analyst here at Jefferies. I have the pleasure of hosting Mike Morrissey, President and CEO of Exelixis. Mike has been kind enough to join us even after going through ASCO, which I can't imagine would have pain that must have...

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

It's been a long week. Yes.

Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

It's been a long week for him, but he is nice enough to still join us. Mike, why don't I give it to you for just some brief introductory remarks, and then we can get into the space together.

Michael M. Morrissey;Akash Tewari
Exelixis, Inc. - CEO, President & Director;Jefferies LLC, Research Division

Thanks again for the invite. Good to see you again.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot